Research Grade Anti-IL-17 & TNF-alpha Bispecific Antibody (COVA322)Anti-IL-17 & TNF-alpha Bispecific Antibody (COVA322) ( HS856226 ) is a research-grade recombinant antibody targeting CD1 . Produced in mammalian cells with native-like glycosylation. Highlights Research Grade — For PK/PD studies, assay development, and ADA research. Native Glycosylation — Mammalian expression ensures native-like patterns. Спецификация| Species reactivity | Human | | Applications | ELISA, Bioactivity: FACS, Functional assay, Research in vivo | | Form | Liquid | | Storage | -20℃ | | Product category | Bispecific Antibodies | | Target | Interleukin-17A, IL-17, IL-17A, Cytotoxic T-lymphocyte-associated antigen 8, CTLA-8, IL17A, Tumor necrosis factor, Cachectin, TNF-alpha, Tumor necrosis factor ligand superfamily member 2, TNF-a, Tumor necrosis factor membrane form, N-terminal fragment, NTF, Intracellular domain 1, ICD1, Intracellular domain 2, ICD2, C-domain 1, C-domain 2, Tumor necrosis factor soluble form, TNF | | Accession | Q16552 & P01375 | | Host species | Human | | | |
Информация для заказа| Область использования: | Производство: | Puda Scientific | | Метод: | Иммуногистохимия | | Объем: | 1mg | | Кат. номер: | PD-A26-15514-100 | | Цена (с НДС 22%): | по запросу | В корзину  | Наименование: Research Grade Anti-IL-17 & TNF-alpha Bispecific Antibody (COVA322).
Примечание: |
|
